Market Cap: $121.12B
Market Cap: $121.12B
Open
$326.50
Prev. Close
$310.72
High
$327.50
Low
$318.03
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries.
Stryker Corporation trades on the New York Stock Exchange under the ticker SYK, priced in USD.
Stryker Corporation has a market capitalisation of $121.12B, based on its latest share price.
SYK trades at 31.24 times its trailing 12-month earnings.
Over the past 52 weeks SYK has traded between $267.00 and $389.33.
Yes. Stryker Corporation's dividend yields 1.16% at the current share price, paying out 35% of its earnings.
Profitable, with a net margin of 14.4% over the last 12 months.
The analyst consensus rating for SYK is Buy.
Kevin A. Lobo is the CEO of Stryker Corporation, which is headquartered in Portage.
Generated automatically from reported financial data. General information only, not financial advice.

Stryker's Growth Amid Supply Chain Turmoil Stryker Corporation ( SYK ) has found itself navigating turbulent waters in recent months, marked by significant developments that challenge its operational…

Stryker Corporation (SYK) actively champions caregiver support in joint replacement recovery through a partnership with golfer Shane Lowry. This initiative seeks to increase awareness of the critical…

In recent developments, Stryker Corporation (Ticker: SYK), a prominent player in the medical technology sector, recalls one of its Neptune Smart Docking Stations, responding to the FDA’s concerns abou…

Stryker Corporation (Ticker: SYK) continues to demonstrate its dedication to innovation in the orthopedic surgical landscape, recently unveiling two significant additions to its product lineup: the Pa…